Debt-to-Equity

Riding a wave of record earnings and strong market trends, American Healthcare REIT is set to make its case to top investors at Nareit's REITweek 2026.

Amid rising flash costs and hardware shortages, one company's record quarter reveals a new, urgent mandate for efficiency and flexibility in IT.

A top financial forum is urging a GST hike, corporate tax cuts, and a radical revamp of retirement savings in its bold 2026 federal budget proposal.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

Investors don VR headsets to tour a utopian Dominican city, fueled by a booming market. But behind the digital polish of Larimar City lies a complex reality.

EastGroup Properties announced its 186th straight dividend, a testament to its financial stability and the enduring resilience of industrial real estate.

With booming revenue and a new premium product on the horizon, Grindr's CFO is set to outline the company's ambitious future to investors this month.

After unprecedented growth, Clear Fork Bank names a new CEO known for community ties, signaling a strategy to blend legacy values with future expansion.

Dream Finders Homes escalates its takeover attempt of Beazer Homes with a public offer, citing a decade of underperformance and a failing strategy.

Advanced Drainage Systems raises its dividend, reflecting robust financial health and a strategy balancing shareholder rewards with strategic growth investments.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

Celebrating a half-century of progress, Liberty Hill Foundation's anniversary gala was an urgent plea to fund the fight for Los Angeles's future.

CFO Martin Fischer's reappointment secures leadership continuity, reinforcing Fresenius Medical Care's focus on financial discipline and long-term growth.

Strong glaucoma sales and disciplined spending helped Iridex narrow its quarterly loss, signaling resilience despite retina segment woes and global headwinds.

Following a record year of profit and growth, the French diagnostics firm secures a major analyst endorsement, signaling a powerful turnaround. What's next?

A new forensic audit claims the global economy is designed to extract value and will hit a structural breaking point by 2030. Is it a system failure?

A $290M war chest fuels a new public biotech aiming to help millions of migraine patients who don't respond to current blockbuster therapies.

The nation's largest EMS provider, GMR Solutions, saw its stock surge on its NYSE debut after a major IPO price cut to appease wary investors.

The firm reported a 3.7% drop in net asset value and a net loss for Q1 2026, raising questions about its dividend sustainability despite a stable payout.

TSLX prices a $300M bond offering and plans a strategic swap to manage risk, signaling confidence and enhancing its firepower in private credit.